Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Zeshan You"'
Publikováno v:
Oncogenesis, Vol 12, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/fcb490981bcc4176b57a4a1cb0d9bbcb
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 499-507 (2021)
Chemotherapy resistance is a bottleneck for ovarian cancer treatment; therefore, revealing its regulatory mechanism is critical. In the present study, we found that prostate tumor overexpressed-1 (PTOV1) was upregulated significantly in ovarian cance
Externí odkaz:
https://doaj.org/article/271cbd1e65074acf9b9c73f45cfff49d
Publikováno v:
Oncogenesis, Vol 10, Iss 1, Pp 1-10 (2021)
Abstract Cisplatin resistance is frequently occurred in ovarian cancer therapy, understanding its regulatory mechanisms is critical for developing novel treatment methods and drugs. Here, we found ovarian cancer patients with low FAM83B levels had sh
Externí odkaz:
https://doaj.org/article/0a6e2b94236d42f68d88d8ff4c4f7e75
Autor:
Yunhui Jiang, Chengyi Zhu, Dan He, Qinglei Gao, Xun Tian, Xin Ma, Jun Wu, Bhudev C. Das, Konstantin Severinov, Inga Isabel Hitzeroth, Priya Ranjan Debata, Rong Liu, Liang Zou, Long Shi, Hua Xu, Kaixiu Wang, Yuxian Bao, Leung Ross Ka-Kit, Zeshan You, Zifeng Cui, Zheng Hu
Publikováno v:
Translational Oncology, Vol 12, Iss 7, Pp 959-967 (2019)
Background: Since human papillomavirus (HPV) DNA testing has been promoted as primary screening strategy, the triage method has also evolved from morphological testing to a molecular biomarker detection to improve screening efficiency. In this study,
Externí odkaz:
https://doaj.org/article/02484634340e4a3aac4947981dab6463
Autor:
Gang Niu, Zhuang Jin, Chong Zhang, Dan He, Xueqin Gao, Chenming Zou, Wei Zhang, Jiahui Ding, Bhudev C. Das, Konstantin Severinov, Inga Isabel Hitzeroth, Priya Ranjan Debata, Xin Ma, Xun Tian, Qinglei Gao, Jun Wu, Zeshan You, Rui Tian, Zifeng Cui, Weiwen Fan, Weiling Xie, Zhaoyue Huang, Chen Cao, Wei Xu, Hongxian Xie, Hongyan Xu, Xiongzhi Tang, Yan Wang, Zhiying Yu, Hui Han, Songwei Tan, Shuqin Chen, Zheng Hu
Publikováno v:
EBioMedicine, Vol 58, Iss , Pp 102897- (2020)
Background: Gene therapy has held promises for treating specific genetic diseases. However, the key to clinical application depends on effective gene delivery. Methods: Using a large animal model, we developed two pharmaceutical formulations for gene
Externí odkaz:
https://doaj.org/article/ef1fae06fa3748d3a15b61c999f849ad
Autor:
Shanyang He, Gang Niu, Jianhong Shang, Yalan Deng, Zhiyong Wan, Cai Zhang, Zeshan You, Hongwei Shen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-12 (2017)
Abstract Background Chemo-resistance is a leading cause of tumor relapse and treatment failure in patients with ovarian cancer. The identification of effective strategies to overcome drug resistance will have a significant clinical impact on the dise
Externí odkaz:
https://doaj.org/article/8b14af91c4c54e14bfd79610b2d244f0
Publikováno v:
Oncogenesis, Vol 10, Iss 2, Pp 1-1 (2021)
A Correction to this paper has been published: https://doi.org/10.1038/s41389-021-00303-4
Externí odkaz:
https://doaj.org/article/575da23c33c9459f80e7da0252c2cd97
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
Unexplained recurrent spontaneous abortion (URSA) is an alloimmune disease associated with the failure of fetal-maternal immunologic tolerance in which the regulatory T lymphocytes (Treg) play a pivotal role. It is well known that Forkhead box P3 (Fo
Externí odkaz:
https://doaj.org/article/ad035195e30c48859742ff7535afea8e
Autor:
Tengjia Jiang, Zeshan You, Weipeng He, Hong-wei Shen, Xiaohui Li, Guofen Yang, Linglong Ouyang, Huiling Lai, Yunyun Guo, Zuwei Zhang
Publikováno v:
Gynecologic Oncology. 160:704-712
Objective To develop a novel diagnostic nomogram model to predict malignancy in patients with ovarian masses. Methods In total, 1277 patients with ovarian masses were retrospectively analyzed. Receiver operating characteristic (ROC) analysis was perf
Publikováno v:
Oncogenesis, Vol 10, Iss 1, Pp 1-10 (2021)
Oncogenesis
Oncogenesis
Cisplatin resistance is frequently occurred in ovarian cancer therapy, understanding its regulatory mechanisms is critical for developing novel treatment methods and drugs. Here, we found ovarian cancer patients with low FAM83B levels had shorter sur